Zoltan Derdak
Company: Takeda Pharmaceuticals
Job title: Medical Director, Early Clinical Development
Seminars:
3:15 pm Identifying MASH Patients with Active Fibrogenesis: Biomarker Strategies for Early Proof-of-Concept Antifibrotic Trials 3:15 pm
Differentiating fibrosis stage from fibrogenic activity in the context of antifibrotic therapy development Leveraging real-world screening data to characterize patients with active, ongoing fibrogenesis Exploring pre-identification tools (including but not limited to AST, FAST score and LiverPRO) and treatment monitoring strategiesRead more
day: Conf Day 1